🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1512)
All (1512)
Buys (112)
Sells (1400)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Amylyx Pharmaceuticals, Inc.
(AMLX)
Bedrosian Camille L
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
6,461
Price
$14.58
Total Value
$94.21K
Shares Held After
169,295
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Amylyx Pharmaceuticals, Inc.
(AMLX)
Mazzariello Gina
— Chief Legal Officer
Mar 2, 2026
Sale
Shares
6,844
Price
$14.52
Total Value
$99.38K
Shares Held After
134,430
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Spyre Therapeutics, Inc.
(SYRE)
Turtle Cameron
— Director
Mar 2, 2026
Sale
Shares
9,100
Price
$42.49
Total Value
$386.66K
Shares Held After
642,540
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Spyre Therapeutics, Inc.
(SYRE)
Turtle Cameron
— Director
Mar 2, 2026
Sale
Shares
5,900
Price
$41.73
Total Value
$246.21K
Shares Held After
651,640
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GENELUX Corp
(GNLX)
Thomas John
— Director
Mar 2, 2026
Sale
Shares
10,000
Price
$2.90
Total Value
$28.96K
Shares Held After
482,784
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
Harris Erik
— EVP & Chief Commercial Officer
Mar 2, 2026
Sale
Shares
10,539
Price
$22.80
Total Value
$240.29K
Shares Held After
89,515
% of Holdings
10.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
KAKKIS EMIL D
— Director
Mar 2, 2026
Sale
Shares
54,404
Price
$22.80
Total Value
$1.24M
Shares Held After
658,994
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROMANO KATHRYN
— Chief Accounting Officer
Mar 2, 2026
Sale
Shares
750
Price
$267.60
Total Value
$200.70K
Shares Held After
22,366
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vir Biotechnology, Inc.
(VIR)
SATO VICKI L
— Director
Mar 2, 2026
Sale
Shares
200
Price
$9.98
Total Value
$2.00K
Shares Held After
1,122,391
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vir Biotechnology, Inc.
(VIR)
SATO VICKI L
— Director
Mar 2, 2026
Sale
Shares
21,800
Price
$9.50
Total Value
$207.19K
Shares Held After
1,122,591
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
FibroBiologics, Inc.
(FBLG)
Davis Jason
— Chief Financial Officer
Mar 2, 2026
Purchase
Shares
70,000
Price
$0.41
Total Value
$28.97K
Shares Held After
70,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IDEAYA Biosciences, Inc.
(IDYA)
Stein Jeffrey
— Director
Mar 2, 2026
Purchase
Shares
50,000
Price
$32.96
Total Value
$1.65M
Shares Held After
54,281
% of Holdings
92.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Ring Christine
— Chief Legal Officer
Mar 2, 2026
Sale
Shares
8,148
Price
$15.44
Total Value
$125.79K
Shares Held After
34,601
% of Holdings
19.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Sandler Laura Lee
— Chief Operating Officer
Mar 2, 2026
Sale
Shares
2,675
Price
$33.81
Total Value
$90.44K
Shares Held After
237,584
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Sandler Laura Lee
— Chief Operating Officer
Mar 2, 2026
Sale
Shares
2,325
Price
$33.28
Total Value
$77.39K
Shares Held After
240,259
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Contineum Therapeutics, Inc.
(CTNM)
Lorrain Daniel S.
— Chief Scientific Officer
Mar 2, 2026
Sale
Shares
4,170
Price
$15.01
Total Value
$62.59K
Shares Held After
151,882
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Contineum Therapeutics, Inc.
(CTNM)
Watkins Tim
— CMO & Head of Development
Mar 2, 2026
Sale
Shares
3,611
Price
$15.02
Total Value
$54.22K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1201–1250 of 1512 transactions (page 25 of 31)
Version: v26.3.33